Clinical Trials Directory

Trials / Completed

CompletedNCT00067899

Oxidative Stress and Vitamin E Requirements

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
99 (planned)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if oxidative stress derived from cigarette smoking increases vitamin E requirements. The study will also assess the role of vitamin C in modulating vitamin E requirements. Vitamin E requirements will be assessed by measuring vitamin E in plasma as well as by measuring the excreted vitamin E metabolite in the urine.

Detailed description

We will be investigating the fractional disappearance rate of tocopherols in cigarette smokers compared to nonsmokers. This will be accomplished by supplementing individuals with deuterium labeled alpha- and gamma-tocopherols. Quantification of plasma tocopherols as well as urinary metabolites, alpha- and gamma-carboxy ethyl hydroxychromanol, will be determined using liquid chromatography/mass spectrometry analysis. In addition, the role of vitamin C as it pertains to its influence on the fraction disappearance rate of vitamin E will also be evaluated.

Conditions

Interventions

TypeNameDescription
DRUGVitamin E with and without Vitamin C

Timeline

Start date
2000-09-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2003-09-08
Last updated
2013-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00067899. Inclusion in this directory is not an endorsement.

Oxidative Stress and Vitamin E Requirements (NCT00067899) · Clinical Trials Directory